Biotech & Cell Therapy Commercialization Strategy
Translate breakthrough science into market-ready therapies with precision analysis of scalability, regulatory readiness, and competitive landscapes.
14 Articles in Biotechnology and Cell Biology
Wearable Bioelectronic Patches for Chronic Disease Monitoring
For decades, the healthcare system has been dependent on periodic checkups and hospital visits to detect and treat illnesses. Today, however, medicine is evolving beyond the clinic, moving directly onto the patient’s skin.
Gene Therapy For Retinal Disease
The retina is a small light-sensitive layer located at the back of the eye that helps the brain create vision by converting light into impulses. When cells or genes in the retina are destroyed, it can lead to visual difficulties or blindness.
Predictive Immunology: AI Models Forecasting Immune Response
The immune system, a complex symphony of cells, chemicals and signals that work together to protect the body, has traditionally been compared to an orchestra. However, despite its great role, it has been one of the most unpredictable "performers" of biology.
Self-Amplifying RNA Vaccines Market: Powering the Next Wave of Scalable Immunization
Self-amplifying RNA (saRNA) vaccines are an advanced version of mRNA vaccines that not only provide genetic guidance for the target antigen but also replicase enzymes so that RNA self-amplify in cells. Due to self-amplification, more antigen expression can be derived from a smaller dose, improving immune response and reducing manufacturing costs.
Cold-Chain and Traceability Solutions for Biologics and Vaccines
The biologics category includes various products such as vaccines, gene therapy and recombinant therapeutic proteins. Biologics and vaccine delivery need a temperature control system that maintains temperature control from storage to transportation and delivery to maintain their effectiveness.
GenAI in the Lab: Accelerating Drug Discovery Through Generative Molecular Design
GenAI in the Lab: Accelerating Drug Discovery Through Generative Molecular DesignThe process of drug invention has long been slow, difficult and costly, relying largely on trial and error. Time, expense and complexity have hindered success. GenAI is offering science a new creative partner, one who can do it with great accuracy, speed and intention.
Pulse: AI-Driven Predictive Biomarkers from Multimodal Data
In the era of precision medicine, the "pulse" of human biology is no longer limited to the heartbeat or blood test; it is a rhythm understood through genes, images, behaviors and electronic footprints.
The Future of Microbiome-Based Therapies
Earlier, the leading causes of diseases were bacteria, tiny living organisms that had to be eradicated at all costs. However, these small creatures are now causing a significant shift in the field of medicine. Bacteria will be the scientific heroes of tomorrow. Since these are being genetically modified, kept in carriers that have been carefully made, and employed as medications.
Bioprinting for Kidney Disease
Renal Diseases Prevalence
AI-Driven Voice Biomarkers: Emerging Solution for Disease Management
AI-Driven Voice Biomarkers: Revolution in Non-Invasive Healthcare Diagnostics
